Credits: None available.
A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency Supported by: Astellas Pharma US, Inc.
Supported by Astellas Pharma US, Inc. This session discusses the clinical impact and physiology of overactive bladder, as well as the latest perspectives on management and treatment.
Request a Rep
You must be logged in and own this session in order to